Table 4 Groups with high risk scores and high risks of death
Follow-up period | 15 years | 10 years | 5 years | |||
|---|---|---|---|---|---|---|
All-cause death | HR (95 % CI) | aHR (95 % CI) | HR (95 % CI) | aHR (95 % CI) | HR (95 % CI) | aHR (95 % CI) |
Group 1 | Reference | Reference | Reference | Reference | Reference | Reference |
Group 2 | 4.66 (2.25, 9.64) | 4.56 (2.20, 9.49) | 3.48 (1.59, 7.62) | 3.23 (1.47, 7.10) | 6.43 (1.54, 26.80) | 5.71 (1.36, 23.92) |
Group 3 | 13.62 (6.48, 28.63) | 15.23 (7.17, 32.34) | 9.41 (4.25, 20.80 | 10.06 (4.50, 22.48) | 16.89 (4.05, 70.44) | 17.29 (4.11, 72.65) |
Group 4 | 20.86 (9.60, 45.31) | 24.96 (11.21, 55.59) | 14.79 6.56, 33.34) | 17.02 (7.36, 39.33) | 24.761 (5.88, 104.34) | 25.25 (5.89, 108.23) |
CVD-caused death | HR (95 % CI) | aHR (95 % CI) | HR (95 % CI) | aHR (95 % CI) | HR (95 % CI) | aHR (95 % CI) |
Group 1 | Reference | Reference | Reference | Reference | Reference | Reference |
Group 2 | 2.59 (1.09, 6.17) | 2.51 (1.05, 6.01) | 2.45 (0.95, 6.34) | 2.32 (0.89, 6.03) | 4.84 (0.63, 37.21) | 4.61 (0.60, 35.58) |
Group 3 | 9.62 (4.03, 22.96) | 10.79 (4.45, 26.17) | 9.20 (3.58, 23.62) | 10.17 (3.90, 26.49) | 22.26 (2.99, 165.50) | 25.89 (3.45, 194.30) |
Group 4 | 14.78 (5.95, 36.74) | 19.06 (7.36, 49.31) | 13.70 (5.17, 36.32) | 17.27 (6.27, 47.54) | 30.66 (4.06, 231.34) | 37.71 (4.87, 291.93) |